Cited by 53

The DOI matches its Crossref record.

All 4 di-leucine motifs in the first hydrophobic domain of the E5 oncoprotein of human papillomavirus type 16 are essential for surface MHC class I downregulation activity and E5 endomembrane localization

Cortese, Marc S., Ashrafi, G. Hossein, Campo, M. Saveria·2010·International Journal of Cancer

Abstract

The E5 oncoprotein of human papillomavirus type 16 downregulates surface MHC Class I and interacts with the heavy chain of the MHC complex via the first hydrophobic domain, believed to form the first helical transmembrane region (TM1) of E5. TM1 contains 4 equally spaced di‐leucine (LL1‐LL4) motifs. Di‐leucine motifs have been implicated in protein–protein interactions and as localization signals. To see if any of the 4 di‐leucine motifs of TM1 are involved in MHC downregulation by E5, we mutated each LL pair into valine pairs (VV1‐VV4), as mutation of leucine to valine is not expected to cause major structural alterations in E5. We found that all 4 mutations disrupted the intracellular location of E5 and abrogated its MHC I downregulating activity; however VV2 and VV4 mutants were still able to interact physically with the MHC I heavy chain (HC) in vitro , while VV1 and VV3 mutants had lost this activity. We conclude that LL1 and LL3 are necessary for the interaction with HC, but LL2 and LL4 are not. However all 4 LL motifs are responsible for the proper localization of E5 in the Golgi/ER, and the displacement of E5 from this location contributes to the abrogation of MHC I downregulation. LL1 and LL3 motifs are expected to be on one face of the TM1 helix and LL2 and LL4 on the opposite face. We propose that E5 interacts with HC via LL1 and LL3 and that all 4 di‐leucine motifs act as a targeting signal.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ijc.25004

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 29

  1. 10.1016/S0168-1702(02)00123-5 · DOI
  2. 10.1016/j.virol.2008.11.046 · DOI · Paper page
  3. 10.1002/ijc.20558 · DOI · Paper page
  4. 10.1002/ijc.22089 · DOI · Paper page
  5. 10.1128/JVI.77.5.2819-2831.2003 · DOI
  6. 10.1128/JVI.77.5.2832-2842.2003 · DOI
  7. Suprynowicz FA, 2006, Papillomavirus Research: From Natural History to Vaccines and Beyond, 97
  8. Leechanachai P, 1992, The E5 gene from human papillomavirus type 16 is an oncogene which enhances growth factor‐mediated signal transduction to the nucleus, Oncogene, 7, 19
  9. 10.1158/0008-5472.CAN-05-0083 · DOI · Paper page
  10. 10.1016/j.virusres.2006.02.005 · DOI
  11. 10.1016/S0042-6822(03)00509-9 · DOI
  12. 10.1186/1475-2867-6-19 · DOI
  13. 10.1006/jmbi.2000.4315 · DOI · Paper page
  14. 10.2144/97233st02 · DOI
  15. 10.1038/sj.onc.1209245 · DOI
  16. 10.4049/jimmunol.177.9.6172 · DOI
  17. 10.1529/biophysj.103.038422 · DOI
  18. 10.1186/1743-422X-5-30 · DOI
  19. 10.1099/vir.0.016295-0 · DOI
  20. 10.1099/0022-1317-81-6-1517 · DOI
  21. Chan SY, 1992, Molecular variants of human papillomavirus type 16 from 4 continents suggest ancient pandemic spread of the virus and its coevolution with humankind, J Virol, 66, 2057, 10.1128/jvi.66.4.2057-2066.1992 · DOI
  22. 10.1128/JVI.79.11.7014-7023.2005 · DOI
  23. 10.1099/0022-1317-80-3-595 · DOI
  24. 10.1007/s00705-004-0325-8 · DOI
  25. 10.1186/1743-422X-4-116 · DOI · Paper page
  26. 10.1093/emboj/18.4.1081 · DOI
  27. 10.1146/annurev.biochem.72.121801.161800 · DOI · Paper page
  28. 10.1128/JVI.01240-08 · DOI
  29. 10.1006/jmbi.1999.3488 · DOI

Metadata

Authors
Cortese, M. S., Ashrafi, G. H., & Campo, M. S.
Venue
International Journal of Cancer
Publisher
Wiley
Published
2010-01-28
Volume
126
Issue
7
Pages
1675-1682
ISSN
  • 0020-7136
  • 1097-0215
Cited by
53
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review